课题基金 / 基金详情

Analysis of expression for HsAIRK and PLK family genes, that regulate chromosome segregation in mitosis, in tumors

Analysis of expression for HsAIRK and PLK family genes, that regulate chromosome segregation in mitosis, in tumors
肿瘤中调节有丝分裂中染色体分离的 HsAIRK 和 PLK 家族基因的表达分析
批准号:
14571188
负责人:
OSADA Shinji
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2002
资助国家:
日本
项目状态:
已结题
起止时间:
2002 至 2005

项目摘要

项目成果

OSADA Shinji的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Aurora family are highly expressed during M phase, and have been suggested to regulate centrosome function, chromosome segregation, and cytokinesis. In addition, PLK family is also intimately involved in spindle formation and chromosome segregation during mitosis. The purpose of this study was to determine whether PLK or Aurora family are overexpressed in primary colorectal cancer specimens as compared with normal colon mucosa and assess its relation to other kinases as a potential new tumor marker.1.PLKIn the present study, immunohistochemical analyses were performed of PLK1 expression in 78 primary colorectal cancers as well as 15 normal colorectal specimens. Furthermore, we examined the relationship between other kinases, Aurora-A and Aurora-C, and PLK1 expression. In normal colon mucosa, some crypt cells showed weak positive staining for PLK1 in 13 out of 15 cases. Elevated expression of PLK1 was observed in 57 (73.1%) of the colorectal cancers, statistically significant associatio … More ns being evident with pT, pN and the Dukes' classification. Values for lesions with high and low PLK1 expression were 54.7±10.3% (mean±SD) and 45.9±11.9%. PLK1 was significantly associated with Aurora-A, but PLK1 staining was more diffuse and extensive than for Aurora-A or Aurora-C.2.AuroraIn the present study, immunohistochemical analyses were performed of HsAIRK1 and HsAIRK3 expression in 78 primary colorectal cancers and 36 colorectal adenomas as well as 15 normal colorectal specimens. Elevated expression of HsAIRK1 was observed in 53 (67.9%) of the colorectal cancers, and of HsAIRK3 in 40 (51.3%). Furthermore, colorectal adenomas showed high expression of HsAIRK1 and HsAIRK3 in 11 (30.6%) and 7 (19.4%) cases, respectively, thus being intermediate between colorectal cancers and normal colorectal mucosa. Interestingly, HsAIRK1 overexpression was significantly associated with p53 accumulation in colorectal cancers.Our results suggest overexpression of PLK1 or Aurora A might be of pathogenic, prognostic and proliferative importance, so that these mitosis-related genes might have potential as a new tumor marker for colorectal cancers. Less
期刊论文(22)
专著(0)
科研奖励(0)
会议论文
加藤 浩樹: "ヒト大腸癌における細胞周期関連遺伝子polo-like kinase (PLK1)及びPLK3の発現に関する検討"外科系連合学会誌. 28巻・1号. (2003)
加藤弘树:“人类结直肠癌中细胞周期相关基因 polo 样激酶 (PLK1) 和 PLK3 的表达”,日本外科学会杂志,第 28 卷,第 1 期(2003 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
ヒト大腸癌における細胞周期関連遺伝子Polo-like kinase(Plk)1およびPlk3の発見に関する検討
人结直肠癌细胞周期相关基因Polo样激酶(Plk)1和Plk3的发现研究
DOI: --
发表时间: 2003
期刊: 日本外科系連合学会誌 28
影响因子: --
作者: [加藤浩樹, 高橋孝夫, 杉山保幸, 國枝克行, 佐治重豊]
通讯作者: 佐治重豊
高橋 孝夫: "Polo-like kinase1 (PLK1) is Overexpressed in Primary Colovectal Cancers"Japanese journal of Cancer Research. (in press).
Takao Takahashi:“Polo 样激酶 1 (PLK1) 在原发性结肠直肠癌中过度表达”,日本癌症研究杂志(正在出版)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
DOI: 10.1002/jso.20006
发表时间: 2004-01-01
期刊: JOURNAL OF SURGICAL ONCOLOGY
影响因子: 2.5
作者: [Osada, S, Saji, S, Kuno, T]
通讯作者: Kuno, T
10
    Cryo-therapy was indicated to induce tumor growth inhibition and immune reation
    • 批准号:
      23591985
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $3.24万
    • 财政年份:
      2011
    • 负责人:
      OSADA Shinji
    • 依托单位:
    国内基金
    海外基金
    CRISPR筛选发现PLK1调控子宫内膜癌进展的机制研究
    千金藤素通过靶向PLK1激活STING/CXCL10重塑肿瘤微环境增效PD-1抑制剂抗非小细胞肺癌机制研究
    • 批准号:
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      江泽波
    • 依托单位:
    脂肪干细胞高表达PLK1促进糖尿病创面中缺氧内皮祖细胞自噬的机制研究
    • 批准号:
      2024Y9037
    • 项目类别:
      省市级项目
    • 资助金额:
      15.0万元
    • 批准年份:
      2024
    • 负责人:
      徐娜婷
    • 依托单位:
    PLK1磷酸化ELF1招募Set1/COMPASS复合体调控胶质瘤谷氨酰胺代谢的机制研究
    • 批准号:
    • 项目类别:
      面上项目
    • 资助金额:
      --
    • 批准年份:
      2024
    • 负责人:
      杨睿
    • 依托单位: